Table 1

Review eligibility criteria based on study population, concept, context and types of evidence

  • Human participants of any description (eg, adults, children, adolescents, older adults, populations with a particular health or medical condition, healthy people)

  • Human samples (eg, tissue samples, genetic material).

  • Analysis of historical datasets (eg, health records, epidemiological datasets).

  • Evaluations of new technologies that do not include human participants (eg, evaluating tensile properties of a new fabric, developing a new medical diagnostic kit/device without in-human testing)

  • Studies that refer to the concept of precision health or its derivatives (eg, personalised health, individualised health, stratified health, tailored health)

  • Any study collecting health-related clinical, psychosocial, or behavioural information (eg, weight loss, disease prevalence/risk, physical activity, mental health)

  • Animal studies, in silico studies, and testing of materials for precision health applications

  • Non-health outcomes including economic outcomes (eg, cost-effectiveness studies), human/sports performance outcomes (eg, physical conditioning programmes for healthy athletes)

  • Any geographical location or setting of any nature (including online studies)

  • None

Types of evidence
  • Primary empirical research studies, (eg, randomised controlled trials, cohort studies, cross-sectional studies, and case reports).

  • Protocols for planned studies

  • Full-text articles

  • Full-text conference proceedings

  • Articles written in English

  • Patents

  • Reviews (eg, systematic reviews, narrative reviews)

  • Editorial articles (eg, perspective pieces, position statements)

  • Abstracts or posters

  • Articles for which we cannot obtain the full text or that are not written in English

  • Dissertations